Technical Specification for Medtronic models including: Medtronic, Crome, HF CRT-D, MRI SureScan, DTPC2D4, ICD, CRT-D, cardiac rhythm management, pacing, defibrillation, MRI conditional, SureScan system

Crome HF CRT-D DF-4 Spec Sheet

Download the spec sheet to learn more about Crome HF CRT-D DF-4 model.

ICD & CRT-D Systems - Crome | Medtronic

PDF preview unavailable. Download the PDF instead.

product-spec-sheet-crome-hf-crt-d-mri-surescan-dtpc2d4 ?bypassIM=true
CromeTM HF CRT-D MRI SureScanTM
Model DTPC2D4

Product specifications

Physical characteristics

Volumea

35 cm3

Mass

82.1 g

H x W x D

73 mm x 51 mm x 13 mm

Surface area of device can 57 cm2

Radiopaque IDb

PLS

Materials in contact with human tissuec

Titanium, polyurethane, silicone rubber, titanium dioxide

Battery

Hybrid CFx lithium/silver vanadium oxide

a Volume with connector ports unplugged. b The radiopaque ID, which includes a Medtronic identifier symbol, can be viewed in a fluoroscopic image of the device. c These materials have been successfully tested for the ability to avoid biological incompatibility. The device does not produce an injurious temperature in the surrounding tissue during normal operation.

Replacement indicators
Recommended Replacement Time (RRT)
End of Service (EOS)

< 2.80 V on 3 consecutive daily automatic measurements
3 months after RRT

Maximum energy levels and typical full energy charge times

Maximum programmed energy

40 J

Maximum delivered energya 40 J

Maximum stored energyb 47 J

Typical charge time
between Beginning of Service (BOS)c and
Recommended Replacement Time (RRT)c

10.5 s

a Energy delivered at connector block into a 50  load. b Energy stored at charge end on capacitor. c Charge time during a nonwireless telemetry session may be slightly higher.

§ BlueSyncTM Technology § Reactive ATPTM Algorithm § SmartShockTM 2.0 Technology § 1.5T and 3T MRI Access* § PhysioCurveTM Design § OptiVolTM 2.0 Fluid Status Monitoring § DF4
*When MR conditions for use are met.

Device parameters

Tachyarrhythmia detection parameters

Parameter

Programmable values

AT/AF Detection

On; Monitor

Zones

1 ;2

AT/AF Atrial Intervala

150 (400); 160 (375) ... 350 (171) ... 450 (133) ms (bpm)

FAST AT/AF Atrial Intervala

150 (400); 160 (375) ... 200 (300) ... 250 (240) ms (bpm)

VF Detectionb

On ; Off

VF Detection Intervala

240 (250); 250 (240) ... 320 (188) ... 400 (150) ms (bpm)

VF Initial Beats to Detect

12/16; 18/24; 24/32; 30/40 ; 45/60; 60/80; 75/100; 90/120; 105/140; 120/160

VF Beats to Redetect

6/8; 9/12; 12/16 ; 18/24; 21/28; 24/32; 27/36; 30/40

FVT Enable

Off ; via VF; via VT

FVT Detection Intervala

200 (300); 210 (286) ... 240 (250) ... 600 (100) ms (bpm)

VT Detection

On; Off

VT Detection Intervala

280 (214); 290 (207) ... 360 (167) ... 650 (92) ms (bpm)

VT Initial Beats to Detect 12; 16 ... 52; 76; 100

VT Beats to Redetect

8; 12 ... 52

Monitor

Monitor ; Off

VT Monitor Intervala

280 (214); 290 (207) ... 450 (133) ... 650 (92) ms (bpm)

Monitored VT Beats to Detect

16; 20 ... 32 ... 56; 80; 110; 130

PR LogicTM/Wavelet

AF/Aflb

On ; Off

Sinus Tachb

On ; Off

Other 1:1 SVTs

On; Off

Waveletb Template Collected Template Evaluated

On ; Off; Monitor [date]c [date]c

Match Threshold

40; 43 ... 70 ... 97%

Auto Collection SVT V. Limita

Off; On 240; 250; 260 ... 650 ms

Other enhancements Stabilitya

Off ; 30; 40 ... 100 ms

Onset

Off ; On; Monitor

Percent

72; 75; 78; 81 ; 84; 88; 91; 94; 97%

High Rate Timeout

VF Zone Only

Off ; 0.25; 0.5; 0.75; 1; 1.25; 1.5; 1.75; 2; 2.5; 3; 3.5; 4; 4.5; 5 min

All Zones

Off ; 0.5; 1; 1.5 ... 5; 6; 7 ... 20; 22; 24; 26; 28; 30 min

T-Wave

On ; Off

RV Lead Noise

On ; Off; On+Timeout

Timeout

0.25; 0.5; 0.75 ... 2 min

a The measured intervals are truncated to a 10 ms multiple (for example, 457 ms becomes 450 ms). The device uses this truncated interval value when applying the programmed criteria and calculating interval averages. b The Wavelet feature is automatically set to On when VF Detection is set to On. c Date is auto-generated.

Atrial tachyarrhythmia detection parameters

Parameter

Programmable values

AT/AF Pacing Therapies

AT/AF Rx Status

On; Off

Therapy Type

Rx1: Ramp ; Burst+; 50 Hz Rx2: Ramp; Burst+ ; 50 Hz Rx3: Ramp ; Burst+; 50 Hz

Fast AT/AF Pacing Therapies

Fast AT/AF Rx Status

On; Off

Therapy Type

Rx1: Ramp ; Burst+; 50 Hz Rx2: Ramp; Burst+ ; 50 Hz Rx3: Ramp ; Burst+; 50 Hz

AT/AF Automatic CV

Automatic CV Status Therapy Type

On; Off CVa; Rx4: CV; Rx5: CV

Energy Pathwayb

0.4; 0.6 ... 1.8; 2; 3 ... 16; 18; 20; 22; 24; 25; 26; 28; 30; 32; 35; 40 J
AX>B; B>AX

Fast AT/AF Automatic CV

Automatic CV Status Therapy Type

On; Off CV a; Rx4: CV; Rx5: CV

Energy Pathwayb

0.4; 0.6 ... 1.8; 2; 3 ... 16; 18; 20; 22; 24; 25; 26; 28; 30; 32; 35; 40 J
AX>B; B>AX

Shared CV

Minimum R-R Intervalc

400 (150); 410 (146) ... 600 (100) ms (bpm)

Active Can/SVC Coild

Can+SVC On ; Can Off; SVC Off

Automatic CV Limits

Start Time

00:00; 01:00; 02:00; 03:00 ... 23:00

Delivery Window Duration

1 ; 2; 3; 4; 6; 8; 10; 12; 16; 20; 24 h

Maximum shocks per day 1 ; 2; 3; 4; 5; No Limit

Episode Duration before Rx

Episode Duration Before CV

0; 1; 2; 3; 4; 5; 7; 10; 15; 20; 25; 30; 40; 50 min; 1; 2; 3; 4; 5; 6 ; 12; 24; 48; 72 h; 7 d

Atrial tachyarrhythmia detection parameters, cont'd.

Parameter

Programmable values

50 Hz parameters

50 Hz Burst Duration

0.5; 1 ; 2; 3 s

# Sequences

1; 2 ... 10

Burst+ parameters

Initial #S1 Pulses

1; 2 ... 11 ; 12; 13; 14; 15; 20; 25

A-S1 Interval (%AA)

28; 31; 34; 38; 41 ... 59; 63; 66 ... 84 ; 88; 91; 94; 97%

S1-S2 (%AA)

Off; 28; 31; 34; 38; 41 ... 59; 63; 66; 69 ... 81 ; 84; 88; 91; 94; 97%

S2-S3 Decrement

Off; 0; 10; 20 ... 80 ms

Interval Decrement

0; 10 ... 40 ms

# Sequences

1; 2 ... 10

Ramp parameters

Initial #S1 Pulses

1; 2 ... 13 ; 14; 15; 20; 25

A-S1 Interval (%AA)

Rx1-Rx2: 28; 31; 34; 38; 41 ... 59; 63; 66 ... 84; 88; 91 ; 94; 97% Rx3: 28; 31; 34; 38; 41 ... 59; 63; 66 ... 81 ; 84; 88; 94; 97%

Interval Decrement

0; 10 ... 40 ms

# Sequences

1; 2 ... 10

Stop Atrial Rx after (shared)

Rx/Lead Suspect

Disable Atrial ATP if it accelerates V. rate?

Yes ; No

Disable all atrial therapies if atrial lead position is suspect? (Atrial Lead Position Check)

Yes ; No

Duration to Stop

None; 12; 24; 48 ; 72 h

Episode Duration before Rx

0; 1 ; 2; 3; 4; 5; 7; 10; 15; 20; Episode Duration before ATP 25; 30; 40; 50 min;
1; 2; 3; 4; 5; 6; 12; 24 h

Reactive ATP

Rhythm Change

On ; Off

Time Interval

Off ; 2; 4; 7; 12; 24; 36; 48 h

Shared Atrial ATP

A-A Minimum ATP Intervalc 100; 110 ...150 ... 400 ms

A. Pacing Amplitude

1; 2; 3 ... 6 ; 8 V

A. Pacing Pulse Width

0.1; 0.2 ... 1.5 ms

VVI/VOO Backup Pacinge

Off; On (Always); On (Auto Enable)

VVI/VOO Backup Pacing Rate 60; 70 ... 120 bpm
a Nonprogrammable. b If the Active Can/SVC Coil parameter is set to Can Off, the Active Can electrode is not used as part of the high-voltage delivery pathway. If the Active Can/SVC Coil parameter is set to SVC Off, the SVC Coil electrode is not used as part of the highvoltage delivery pathway.

c The measured intervals are truncated to a 10 ms multiple (for example, 457 ms becomes 450 ms). The device uses this truncated interval value when applying the programmed criteria and calculating interval averages. d The Active Can/SVC Coil parameter applies to all automatic, manual, and emergency high-voltage therapies. It also applies to T-Shock inductions. e If V. Pacing is programmed to LV, V. Backup Pacing is delivered to the LV chamber. Otherwise, V. Backup Pacing is delivered to the RV chamber.

Ventricular tachyarrhythmia therapy parameters

Parameter

Programmable values

VF Therapies

VF Therapy Status

On ; Off

Energy

Rx1-Rx2: 0.4; 0.6 ... 1.8; 2; 3 ... 16; 18; 20; 22; 24; 25; 26; 28; 30; 32; 35; 40 J Rx3-Rx6: 10; 11 ... 16; 18; 20; 22; 24; 25; 26; 28; 30; 32; 35; 40 J

Pathwaya

AX>B; B>AX Rx1-Rx4: B>AX Rx5-Rx6: AX>B

VF ATP

Therapy Status

On ; Off

Therapy Type

Ramp; Burst ; Ramp+

Deliver ATP if last 8 R-R  200; 210 ... 240 ... 300 ms

# Sequences Before Charging

Ramp, Burst, Ramp+: 0 ; 1

# Sequences During Charging

1

Initial # Pulses

Ramp: 1; 2 ... 6 ... 15 Burst: 1; 2 ... 8 ... 15 Ramp+: 1; 2; 3 ... 15

R-S1 Interval = (%RR)

Ramp: 50; 53; 56; 59; 63; 66 ... 84; 88; 91 ; 94; 97% Burst: 50; 53; 56; 59; 63; 66 ... 84; 88 ; 91; 94; 97% Ramp+: 50; 53; 56; 59; 63; 66; 69; 72; 75 ; 78; 81; 84; 88; 91; 94; 97%

Interval Dec

Ramp, Burst: 0; 10 ... 40 ms

ChargeSaver Smart Modeb

On ; Off On ; Off

S1S2 (Ramp+) = (%RR)

50; 53; 56; 59; 63; 66; 69 ... 81; 84; 88; 91; 94; 97%

S2SN (Ramp+) = (%RR)

50; 53; 56; 59; 63; 66 ; 69 ... 81; 84; 88; 91; 94; 97%

FVT Therapies/VT Therapies

FVT Therapy Status

On; Off

VT Therapy Status Therapy Typed,e

On; Off CV; Burst; Ramp; Ramp+

Smart Mode

Rx1-Rx4: On; Off

# Sequences

Burst, Ramp, Ramp+: VT therapies: 1; 2; 3 ... 10 FVT therapies: 1 ; 2 ... 10

Initial # Pulses

Ramp: 1; 2 ... 6 ... 15 Burst: 1; 2 ... 8 ... 15 Ramp+: 1; 2; 3 ... 15

Ventricular tachyarrhythmia therapy parameters, cont'd.

Parameter

Programmable values

R-S1 Interval = (%RR)

Burst: 50; 53; 56; 59; 63; 66 ... 84; 88 ; 91; 94; 97% Ramp: 50; 53; 56; 59; 63; 66 ... 84; 88; 91 ; 94; 97% Ramp+: 50; 53; 56; 59; 63; 66; 69; 72; 75 ; 78; 81; 84; 88; 91; 94; 97%

S1S2 (Ramp+) = (%RR)

50; 53; 56; 59; 63; 66; 69 ... 81; 84; 88; 91; 94; 97%

S2SN (Ramp+) = (%RR)

50; 53; 56; 59; 63; 66 ; 69 ... 81; 84; 88; 91; 94; 97%

Interval Dec

Burst, Ramp: 0; 10 ... 40 ms

CV for FVT and VT therapies

Energy

0.4; 0.6 ... 1.8; 2; 3 ... 16; 18; 20; 22; 24; 25; 26; 28; 30; 32; 35; 40 J VT Rx1-Rx2: 20 J VT Rx3-Rx6: 40 J FVT Rx1-Rx6: 40 J

Pathwaya

AX>B; B>AX Rx1-Rx4: B>AX Rx5-Rx6: AX>B

Shared V. ATP

V-V Minimum ATP Interval 150; 160 ... 200 ... 400 ms

V. Amplitude

1; 2; 3 ... 6; 8 V

V. Pulse Width

0.1; 0.2 ... 1.5 ms

V. Pace Blanking

170 ; 180; 190 ... 450 ms

V. Pacinge

RV ; LV  RV; LV

Shared V. Therapies

Active Can/SVC Coilf

Can+SVC On ; Can Off; SVC Off

Progressive Episode Therapies

On; Off

Confirmation+

On ; Off

a If the Active Can/SVC Coil parameter is set to Can Off, the Active Can electrode is not used as part of the high-voltage delivery pathway. If the Active Can/SVC Coil parameter is set to SVC Off, the SVC Coil electrode is not used as part of the highvoltage delivery pathway. b Smart Mode is available for Rx1-Rx4. c FVT therapies must be increasingly aggressive. d Last therapy that is programmed to On must be a CV. e If RV+LV is selected, the ATP therapy is delivered LVRV with a 2.5 ms delay. f The Active Can/SVC Coil parameter applies to all automatic, manual, and emergency high-voltage therapies. It also applies to T-Shock inductions.

Pacing parameters

Modes, rates, and intervals

Parameter

Programmable values

Mode

DDDR; DDD ; AAIR<=>DDDR; AAI<=>DDD; DDIR; DDI; AAIR; AAI; VVIR; VVI; DOO; AOO; VOO; ODO

Mode Switch

On ; Off

Lower Ratea

30; 35 ... 50 ; 55; 60; 70; 75 ... 150 bpm

Upper Tracking Rate

80; 85 ... 130 ... 175 bpm

Paced AV

30; 40 ... 130 ... 350 ms

Sensed AV

30; 40 ... 100 ... 350 ms

PVARP

Auto ; 150; 160 ... 500 ms

Minimum PVARP

150; 160 ... 250 ... 500 ms

A. Refractory Period

150; 160 ... 310 ... 500 ms

a The corresponding Lower Rate Interval can be calculated as follows: Lower Rate Interval (ms) = 60,000/Lower Rate.

Atrial pacing parameters

Parameter

Programmable values

A. Amplitude

0.50; 0.75 ... 1.25; 1.50; 1.75 ... 3.50 ... 5.00; 5.50; 6.00; 8.00 V

A. Pulse Width

0.03; 0.06; 0.10; 0.20; 0.30; 0.40 ... 1.50 ms

Atrial Sensitivitya

Off; 0.15; 0.30 ; 0.45; 0.60; 0.90; 1.20; 1.50; 1.80; 2.10; 4.00 mV

a This setting applies to all sensing in this chamber for both tachyarrhythmia detection and bradycardia pacing operations.

RV pacing parameters

Parameter

Programmable values

RV Amplitude

0.50; 0.75 ... 1.25; 1.50; 1.75 ... 3.50 ... 5.00; 5.50; 6.00; 8.00 V

RV Pulse Width

0.03; 0.06; 0.10; 0.20; 0.30; 0.40 ... 1.50 ms

RV Sensitivitya

0.15; 0.30 ; 0.45; 0.60; 0.90; 1.20 mV

Pace Polarity

Bipolar; Tip to Coil

Sense Polarity

Bipolar; Tip to Coil

a This setting applies to all sensing in this chamber for both tachyarrhythmia detection and bradycardia pacing operations.

LV parameters Parameter LV Amplitude
LV Pulse Width LV Pace Polarity

Programmable values
0.50; 0.75 ... 1.25; 1.50; 1.75 ... 3.50 ... 5.00; 5.50; 6.00; 8.00 V
0.03; 0.06; 0.10; 0.20; 0.30; 0.40 ... 1.50 ms
LVtip to RVcoil; LVring to RVcoil; LVtip to LVring; LVring to LVtip

CRT parameters Parameter V. Pacing V-V Pace Delay V. Sense Response Maximum Rate Atrial Tracking Recovery

Programmable values RV; LV; RVLV; LVRV 0 ; 10 ... 80 ms On ; Off 95; 100 ... 130 ... 150 bpm On ; Off

Atrial Capture ManagementTM parameters

Parameter

Programmable values

Atrial Capture Management Adaptive ;Off; Monitor

Atrial Amplitude Safety Margin

1.5x ; 2.0x; 2.5x; 3.0x

Atrial Minimum Adapted Amplitude

1.0; 1.5 ; 2.0; 2.5; 3.0; 3.5 V

Atrial Acute Phase Remaining Off; 30; 60; 90; 120 ; 150 days

RV Capture Management parameters

Parameter

Programmable values

RV Capture Management Adaptive ;Off; Monitor

RV Amplitude Safety Margin 1.5x ; 2.0x; 2.5x; 3.0x

RV Minimum Adapted Amplitude

1.0; 1.5; 2.0 ; 2.5; 3.0; 3.5 V

RV Acute Phase Remaining Off; 30; 60; 90; 120 ; 150 days

LV Capture Management parameters

Parameter

Programmable values

LV Capture Management LV Amplitude Safety Margin

Adaptive ; Off; Monitor
+ 0.5; + 1.0; + 1.5; + 2.0; + 2.5 V; + Auto

LV Maximum Adapted Amplitude

0.50; 0.75 ... 5.00; 5.50; 6.00 V

Blanking periods

Parameter PVAB Interval PVAB Method

Programmable values
10; 20 ... 150 ... 300 msa 100; 110 ... 150 ... 300 msb
Partial ; Partial+; Absolutec

A. Blank Post AP

150; 160 ... 200 ... 250 ms

A. Blank Post AS

100 ; 110 ... 170 ms

V. Blank Post VP

170; 180 ... 200 ... 450 ms

V. Blank Post VS

120 ; 130 ... 170 ms

a When PVAB Method = Partial+ or Absolute. b When PVAB Method = Partial. c Programming the PVAB method to Absolute automatically resets the interval to 30 ms. If the PVAB method is programmed to Partial or Partial+, the interval resets to 150 ms.

Rate Response pacing parameters

Parameter

Programmable values

Upper Sensor Rate

80; 85 ... 120 ... 175 bpm

ADL Rate

60; 65 ... 95 ... 170 bpm

Rate Profile Optimization On ; Off

ADL Response

1; 2; 3 ; 4; 5

Exertion Response

1; 2; 3 ; 4; 5

Activity Threshold

Low ; Medium Low; Medium High; High

Activity Acceleration

15; 30 ; 60 s

Activity Deceleration

Exercise ; 2.5; 5; 10 min

ADL Setpoint

5; 6 ... 40; 42 ... 80

UR Setpoint

15; 16 ... 40; 42 ... 80; 85 ... 180

Rate Adaptive AV parameters

Parameter Rate Adaptive AV

Programmable values Off; On

Start Rate

50; 55 ... 90 ... 145 bpm

Stop Rate Minimum Paced AV

55; 60 ... 130 ... 175 bpm 30; 40 ... 100 ... 200 ms

Minimum Sensed AV

30; 40 ... 70 ... 200 ms

Atrial Rate Stabilization parameters

Parameter

Programmable values

A. Rate Stabilization

On; Off

Maximum Rate

80; 85 ... 100 ... 150 bpm

Interval Percentage Increment

12.5; 25 ; 50%

Atrial Preference Pacing parameters

Parameter

Programmable values

A. Preference Pacing

On; Off

Maximum Rate

80; 85 ... 100 ... 150 bpm

Interval Decrement

30 ; 40 ... 100; 150 ms

Search Beats

5; 10; 15; 20 ; 25; 50

Post Mode Switch Overdrive Pacing parameters

Parameter

Programmable values

Post Mode Switch Overdrive Rate

On; Off 70; 75; 80 ... 120 bpm

Overdrive Duration

0.5; 1; 2; 3; 5 ; 10; 20; 30; 60; 90; 120 min

Conducted AF response parameters

Parameter

Programmable values

Conducted AF Response On ; Off

Response Level

Low; Medium ; High

Maximum Rate

80; 85 ... 110 ... 130 bpm

Ventricular Rate Stabilization parameters

Parameter

Programmable values

V. Rate Stabilization

On; Off

Maximum Rate

80; 85 ... 100 ... 120 bpm

Interval Increment

100; 110 ... 150 ... 400 ms

Post VT/VF shock pacing parameters

Parameter

Programmable values

Post VT/VF Shock Pacing On; Off

Overdrive Rate

70; 75; 80 ... 120 bpm

Overdrive Duration

0.5 ; 1; 2; 3; 5; 10; 20; 30; 60; 90; 120 min

Post shock pacing parameters

Parameter

Programmable values

Post Shock A. Amplitude

1.0; 2.0; 3.0; 4.0 ; 5.0; 6.0; 8.0 V

Post Shock A. Pulse Width 0.1; 0.2 ... 1.5 ms

Post Shock V. Amplitudea Post Shock V. Pulse Widtha

1; 2 ... 6 ; 8 V 0.1; 0.2 ... 1.5 ms

a Applies to all ventricular chambers paced.

Rate Drop Response parameters

Parameter Rate Drop Responsea

Programmable values On; Off

Detection Type

Drop ; Low Rate; Both

Drop Size

10; 15 ... 25 ... 50 bpm

Drop Rate

30; 40 ... 60 ... 100 bpm

Detection Window

10; 15; 20; 25; 30 s 1 ; 1.5; 2; 2.5 min

Detection Beats

1; 2; 3 beats

Intervention Rate

70; 75 ... 100 ... 150 bpm

Intervention Duration

1; 2 ... 15 bpm

a When Rate Drop Response is programmed to On, the Lower Rate is automatically set to 45 bpm.

Sleep parameters Parameter Sleep Sleep Rate
Bed Time
Wake Time

Programmable values
On; Off
30; 35 ... 50 ; 55; 60; 70; 75 ... 100 bpm
00:00; 00:10 ... 22:00 ... 23:50
00:00; 00:10 ... 07:00 ... 23:50

Non-Competitive Atrial Pacing (NCAP) parameters

Parameter Non-Comp Atrial Pacing

Programmable values On ; Off

NCAP Interval

200; 250; 300 ; 350; 400 ms

MRI SureScan parameters Parameter MRI SureScan
MRI Pacing Mode
MRI Pacing Rate

Programmable values
On; Off
DOO (asynchronous); AOO (asynchronous); VOO (asynchronous); ODO (off)
60; 70; 75 ... 120 bpm

Additional pacing features

Parameter

Programmable values

PMT Intervention

On ; Off

PVC Response

On ; Off

V. Safety Pacinga

On ; Off

a Delivered as LV pacing when LV pacing is permanently programmed. Delivered as RV pacing when RV only pacing is permanently programmed. Otherwise, delivered as Bi-V pacing.

Medtronic CareAlertTM parameters

Clinical management alerts

Parameter

Programmable values

OptiVol 2.0 Fluid Settings

Device Tone and Wireless Alert

OptiVol Alert enable

Device Tone

Off ; On; Suspend 3 days; Suspend 5 days; Suspend 7 days; Suspend 14 days

Wireless Alert OptiVol Thresholdb

Off ; On 30; 40: 50; 60 ... 180

AT/AF Burden and Rate Settings

Device Tone and Wireless Alert

AT/AF Daily Burden

Off ; On

Daily AT/AF Burden

0.5; 1; 2; 6 ; 12; 24 h

Avg. V. Rate during AT/AF Off ; On

Avg. V. Rate during AT/AF Burden Time

0.5; 1; 2; 6 ; 12; 24 h

Avg. V. Rate during AT/AF 90; 100 ... 150 bpm

VT/VF Episodes and Therapies

Device Tone and Wireless Alert

Monitored VT Episode Detected

Off ; On

Thresholds

1 episode

Daily VT/VF Episodes

Off ; On

Thresholds

3 episodes/day

Weekly ATP Delivered Episodes

Off ; On

Thresholds

1 ; 2; 3; 4; 5

Number of Shocks Delivered in an Episoded

Off

; On

Thresholdsc

1 ; 2; 3; 4; 5; 6

Clinical management alerts, cont'd.

Parameter

Programmable values

Total VP < 90%

Device Tone and Wireless Alert

Off ; Ona

a Alert triggered if percent of cumulative right ventricular pacing is greater than 40% for 7 consecutive days. b Decreasing the OptiVol Threshold makes the device more sensitive to changes in the patient's thoracic fluid status. Increasing the OptiVol Threshold could delay or prevent device observation of significant changes in the patient's thoracic fluid status. c This parameter is displayed only if an associated alert has been enabled. d Note that VF, VT, and FVT therapies could be delivered during a single episode (from initial detection until episode termination).

Lead/device integrity alerts

Parameter

Programmable values

RV Lead

Device Tone and Wireless Alert

RV Lead Integrity

On ; Off

RV Lead Noise

On ; Off

Lead Impedance Out of Range

Device Tone and Wireless Alert

A. Pacing Enable

On ; Off

A. Pacing Less than

200 ; 300; 400; 500 

A. Pacing Greater than 1,000; 1,500; 2,000; 3,000 

RV Pacing Enable

On ; Off

RV Pacing Less than

200 ; 300; 400; 500 

RV Pacing Greater than 1,000; 1,500; 2,000; 3,000 

LV Pacing Enable

On ; Off

LV Pacing Less than

200 ; 300; 400; 500 

LV Pacing Greater than

800; 1,000; 1,500; 2,000; 3,000 

RV Defibrillation Enable

On ;Off

RV Defibrillation Less than 20 ; 30; 40; 50 

RV Defibrillation Greater than
SVC Defibrillation Enablea

100; 130; 160; 200  On ; Off

SVC Defibrillation Less than

20 ; 30; 40; 50 

SVC Defibrillation Greater than

100; 130; 160; 200



Capture Management High Threshold

Device Tone and Wireless Alert

A. Capture

Off ; On

RV Capture

Off ; On

LV Capture

Off ; On

Low Battery Voltage RRT

Device Tone and Wireless Alert

On ; Off

Excessive Charge Time EOS

Device Tone and Wireless Alert

On ; Off

VF Detection Off, 3+ VF or 3+ FVT Rx Off

Device Tone and Wireless Alert

On ; Off

a If an SVC lead is not implanted, the alert will not sound.

Shared parameters

Parameter

Programmable values

Wireless Telemetry with Monitor Alert Time (OptiVol)a
Alert Time (all others)a

On ; Off
00:00; 00:10 ... 10:10 ... 23:50b 00:00; 00:10 ... 08:00 ... 23:50b

a This parameter is displayed only if an associated alert has been enabled. b The implantable device app expresses time in the 24-hour format or in the 12-hour format, depending on your tablet settings.

Data collection parameters

Data collection parameters

Parameter
LECG Source (Leadless ECG)a

Programmable values
Can to SVC b,c; Can to Aring; RVcoil to Aring

LECG Range (Leadless ECG)

±1; ±2 ; ±4; ±8; ±12; ±16; ±32 mV

EGM 1 Source

RVtip to RVring; RVtip to RVcoil; Atip to RVring; Atip to Aring ; Aring to RVring; Aring to RVcoil

EGM 1 Range

±1; ±2; ±4; ±8 ; ±12; ±16; ±32 mV

EGM 2 Source

Can to RVcoil ; Can to RVring; RVtip to RVcoil; RVtip to RVring; Can to SVCb,c; RVcoil to SVCb; LVtip to SVCb; Can to LVtip; RVtip to LVtip

EGM 2 Range

±1; ±2; ±4; ±8; ±12 ; ±16; ±32 mV

EGM 3 Source

RVtip to RVcoil; RVtip to RVring ; LVtip to LVringd; LVtip to RVring; LVtip to RVcoil; LVring to RVcoil; Can to RVcoil

EGM 3 Range

±1; ±2; ±4; ±8 ; ±12; ±16; ±32 mV

Monitored

EGM1 and EGM2; EGM1 and EGM3 ; EGM2 and EGM3; EGM1 and LECG; EGM2 and LECG; EGM3 and LECG

Pre-arrhythmia EGM

Off; On Continuous

V. Sensing Episodes

Collect if Consecutive VS 

5; 8; 10 ; 15; 20; 30; 40; 50; 100; 150; 200 senses

Data collection parameters, cont'd.

Parameter

Programmable values

End collection if Consecutive VP 

2; 3 ; 5; 10 paces

Device Date/Timee

(select time zone)

Holter Telemetry Duration

Off ; 0.5; 1; 2; 4; 8; 16; 24; 36; 46 h

a This EGM channel displays far-field signals. To display an approximation of a surface ECG signal, choose the Can to SVC EGM source. b An SVC electrode must be present for this configuration. c If the Can to SVC source is selected, the EGM Range is automatically set to ±2 mV. The EGM Range is automatically set to ±8 mV for all other EGM Source options. d A bipolar LV lead must be present for this configuration. e The times and dates stored in episode records and other data are determined by the Device Date/Time clock.

CardioSyncTM Optimization test parameters

Sensing Lower Rate

30; 35 ... 60; 70; 75 ... 90 bpm

Pacing Lower Rate

35; 40 ... 60; 70; 75 ... 95 bpm

Wavelet Test parameters

Match Threshold

40; 43 ... 70 ... 97%

Modea

ODO; AAI; VVI; DDD; DDI

AV Delay

30; 40 ... 350 ms

Lower Rate

30; 35 ... 60; 70; 75 ... 120 bpm

a The selectable values for this parameter depend on the programmed pacing mode. b When performing the test in DDD mode, the Lower Rate must be less than the programmed Upper Tracking Rate. c The selectable values for this parameter depend on the programmed PVAB values.

System test parameters

System test parameters

Parameter

Selectable values

Pacing Threshold Test parameters

Test Type (Atrium or RV test)

Amplitude; Pulse Width

Test Type (LV test)

Amplitude; Pulse Width; Phrenic Nerve Stim -- Amplitude; Phrenic Nerve Stim -- Pulse Width

Chamber

Atrium; RV; LV

Decrement after

2; 3 ... 15 pulses

RV Pace Polarity

Bipolar; Tip to Coil

LV Pace Polarity
Modea (RV or LV Test) Modea (Atrium Test) Lower Rateb

LVtip to RVcoil; LVtip to LVring;LVring to RVcoil; LVring to LVtip
VVI; VOO; DDI; DDD; DOO
AAI; AOO; DDI; DDD; DOO
30; 35 ... 60; 70; 75 ... 150 bpm

RV Amplitude

0.25; 0.5 ... 5; 5.5; 6; 8 V

RV Pulse Width

0.03; 0.06; 0.1; 0.2 ... 1.5 ms

LV Amplitude

0.25; 0.5 ... 5; 5.5; 6; 8 V

LV Pulse Width

0.03; 0.06; 0.1; 0.2 ... 1.5 ms

A. Amplitude

0.25; 0.5 ... 5; 5.5; 6; 8 V

A. Pulse Width

0.03; 0.06; 0.1; 0.2 ... 1.5 ms

AV Delay

30; 40 ... 350 ms

V. Pace Blanking

150; 160 ... 450 ms

A. Pace Blanking

150; 160 ... 250 ms

PVARPc

150; 160 ... 500 ms

Sensing Test parameters Modea

AAI; DDD; DDI; VVI; ODO

AV Delay Lower Rateb

30; 40 ... 350 ms 30; 35 ... 60; 70; 75 ... 120 bpm

EP study parameters

T-Shock parameters

Parameter Chambera

Selectable values RV ; LV; RV+LV

Resume at Deliver

Enabled ; Disabled

Enable

Enabled; Disabled

#S1

2; 3; 4; 5 ; 6; 7; 8

S1S1

300; 310 ... 400 ... 2,000 ms

Delay

20; 30 ... 300 ... 600 ms

Energy/Pathway

Energy Pathwayb

0.4; 0.6; 0.8; 1.0 ... 1.8; 2; 3; 4 ... 16; 18; 20; 22; 24; 25; 26; 28; 30; 32; 35; 40 J
AX>B; B>AX

Waveform

Monophasic ; Biphasic

a If the chamber selected is RV+LV, the delay is set to 2.5 ms with LV pace delivered first. b If the Active Can/SVC Coil parameter is set to Can Off, the Active Can electrode is not used as part of the high-voltage delivery pathway. If the Active Can/SVC Coil parameter is set to SVC Off, the SVC Coil electrode is not used as part of the high-voltage delivery pathway.

50 Hz Burst parameters

Parameter

Selectable values

Resume at Burst

Enabled ; Disabled

Chamber Amplitudea Pulse Widtha

Atrium; RV; LV 1; 2; 3; 4 ; 5; 6; 8 V 0.10; 0.20 ... 0.50 ... 1.50 ms

VOO Backup (for atrial 50 Hz burst)b

On; Off

Pacing Rate

60; 70 ... 120 bpm

V. Amplitudec,d

0.50; 0.75 ... 5.00; 5.50; 6.00; 8.00 V

V. Pulse Widthc,d

0.10; 0.20 ... 1.50 ms

a Applies to all ventricular chambers paced. b If V. Pacing is set to RV, RVLV, or LVRV, then backup pacing is delivered to the RV chamber. If V. Pacing is set to LV, then backup pacing is delivered to the LV chamber. c The default value for this parameter is set according to the permanently programmed settings for bradycardia pacing. d Crosstalk may occur when atrial pacing amplitude is > 6.0 V.

Fixed Burst parameters

Parameter

Selectable values

Resume at Burst Chambera

Enabled ; Disabled Atrium; RV; RV+LV; LV

Interval Amplitudeb Pulse Widthb

100; 110 ... 600 ms 1; 2; 3; 4 ; 5; 6; 8 V 0.10; 0.20 ... 0.50 ... 1.50 ms

VVI Backup (for atrial fixed burst)c

On; Off

Pacing Rate

60; 70 ... 120 bpm

V. Amplituded,e

0.50; 0.75 ... 5.00; 5.50; 6.00; 8.00 V

V. Pulse Widthd

0.10; 0.20 ... 1.50 ms

a If the chamber selected is RV+LV, the delay is set to 2.5 ms with LV pace delivered first. b Applies to all ventricular chambers paced. c If V. Pacing is set to RV, RVLV, or LVRV, then backup pacing is delivered to the RV chamber. If V. Pacing is set to LV, then backup pacing is delivered to the LV chamber. d The default value for this parameter is set according to the permanently programmed settings for bradycardia pacing. e Crosstalk may occur when atrial pacing amplitude is > 6.0 V.

PES induction parameters

Parameter

Selectable values

Resume at Deliver

Enabled ; Disabled

Chambera

Atrium; RV; RV+LV; LV

#S1

1; 2 ... 8 ... 15

S1S1

100; 110 ... 600 ... 2,000 ms

S1S2

On; Off; 100; 110 ... 400 ... 600 ms

S2S3

On; Off ; 100; 110 ... 600 msb

S3S4

On; Off ; 100; 110 ... 600 msb

Amplitudec

1; 2; 3; 4 ; 5; 6; 8 V

Pulse Widthc

0.10; 0.20 ... 0.50 ... 1.50 ms

VVI Backup (for atrial PES)d On; Off

Pacing Rate

60; 70 ... 120 bpm

V. Amplitudee,f

0.50; 0.75 ... 5.00; 5.50; 6.00; 8.00 V

V. Pulse Widthe

0.10; 0.20 ... 1.50 ms

a If the chamber selected is RV+LV, the delay is set to 2.5 ms with LV pace delivered first. b Default value when parameter is programmed to On is 400 ms. c Applies to all ventricular chambers paced. d If V. Pacing is set to RV, RVLV, or LVRV, then backup pacing is delivered to the RV chamber. If V. Pacing is set to LV, then backup pacing is delivered to the LV chamber. e The default value for this parameter is set according to the permanently programmed settings for bradycardia pacing. f Crosstalk may occur when atrial pacing amplitude is > 6.0 V.

Defibrillation parameters

Parameter

Selectable values

Chamber

RV

Energy

0.4; 0.6 ... 1.8; 2; 3 ... 16; 18; 20; 22; 24; 25; 26; 28; 30; 32; 35; 40 J

Pathwaya

AX>B; B>AX

a If the Active Can/SVC Coil parameter is set to Can Off, the Active Can electrode is not used as part of the high-voltage delivery pathway. If the Active Can/SVC Coil parameter is set to SVC Off, the SVC Coil electrode is not used as part of the high-voltage delivery pathway.

Cardioversion parameters

Parameter

Selectable values

Chamber

Atrium; RV

Energy Pathwaya

0.4; 0.6 ... 1.8; 2; 3 ... 16; 18; 20; 22; 24; 25; 26; 28; 30; 32; 35; 40 J
AX>B; B>AX

Minimum R-R (atrial CV only) 400; 410 ... 500 ... 600 ms
a If the Active Can/SVC Coil parameter is set to Can Off, the Active Can electrode is not used as part of the high-voltage delivery pathway. If the Active Can/SVC Coil parameter is set to SVC Off, the SVC Coil electrode is not used as part of the high-voltage delivery pathway.

Shared ATP parametersa

Parameter

Selectable values

Minimum Interval (atrial ATP) 100; 110; 120; 130 ... 400 ms

Minimum Interval (ventricular ATP)
Amplitudeb
Pulse Widthb

150; 160 ... 200 ... 400 ms
1; 2 ... 6 ; 8 V 0.10; 0.20 ... 1.50 ms

VVI Backup (for atrial ATP studies)c

On; Off

Pacing Rate

60; 70 ... 120 bpm

V. Amplituded,e

0.50; 0.75 ... 5.00; 5.50; 6.00; 8.00 V

V. Pulse Widthd

0.10; 0.20 ... 1.50 ms

a Ramp, Burst, Ramp+ and Burst+. b Applies to all ventricular chambers paced. c If V. Pacing is set to RV, RVLV, or LVRV, then backup pacing is delivered to the RV chamber. If V. Pacing is set to LV, then backup pacing is delivered to the LV chamber. d The default value for this parameter is set according to the permanently programmed settings for bradycardia pacing. e Crosstalk may occur when atrial pacing amplitude is > 6.0 V.

Ramp parameters

Parameter Chambera

Selectable values Atrium; RV; RV+LV; LV

Ventricular Ramp study parameters

# Pulses

1; 2 ... 6 ... 15

%RR Interval

50; 53; 56; 59; 63; 66 ... 84; 88; 91; 94; 97 %

Dec/Pulse

0; 10 ; 20; 30; 40 ms

Atrial Ramp study parameters

# Pulses

1; 2 ... 6 ... 15; 20; 30 ... 100

%AA Interval

28; 31; 34; 38; 41 ... 59; 63; 66 ... 84; 88; 91; 94; 97 %

Dec/Pulse

0; 10 ; 20; 30; 40 ms

a If the chamber selected is RV+LV, the delay is set to 2.5 ms with LV pace delivered first.

Burst parameters

Parameter Chambera

Selectable values RV ; RV+LV; LV

# Pulses

1; 2 ... 8 ... 15

%RR Interval

50; 53; 56; 59; 63; 66 ... 84; 88 ; 91; 94; 97%

a If the chamber selected is RV+LV, the delay is set to 2.5 ms with LV pace delivered first.

Ramp+ parameters

Parameter Chambera

Selectable values RV ; RV+LV; LV

# Pulses

1; 2; 3 ... 15

R-S1 (%RR)

50; 53; 56; 59; 63; 66 ... 75 ... 84; 88; 91; 94; 97%

S1S2 (%RR)

50; 53; 56; 59; 63; 66; 69 ... 84; 88; 91; 94; 97%

S2SN (%RR)

50; 53; 56; 59; 63; 66 ... 84; 88; 91; 94; 97%

a If the chamber selected is RV+LV, the delay is set to 2.5 ms with LV pace delivered first.

Burst+ parameters Parameter Chamber #S1 Pulses
%AA Interval
S1S2
S2S3 Dec
a This value is nonprogrammable.

Selectable values Atriuma
1; 2 ... 6 ... 15; 20; 30 ... 100
28; 31; 34; 38; 41 ... 59; 63; 66 ... 84; 88; 91 ; 94; 97%
Off; 28; 31; 34; 38; 41 ... 59; 63; 66 ... 84 ; 88; 91; 94; 97%
Off; 0; 10; 20 ... 80 ms

Longevity

Projected service life in years

RA amplitude/pace % RV amplitude/pace % LV amplitude/pace % Projected service life per impedance

1.5 V, 0% 1.5 V, 13% 1.5 V, 100%

2.0 V, 100% 2.0 V, 100% 2.0 V, 100%

1.75 V, 100% 1.75 V, 100% 1.75 V, 100%

500  9.6 yearsa
9.4 yearsa

RA 435 /RV 430 /LV 568  9.5 yearsb

2.5 V, 15%

2.5 V, 100%

2.5 V, 100%

8.3 years

600 : 8.7 years

a Per EN 45502-2-2 or ISO 14708-6 for paced percentage and lead impedance. b Based on median CareLinkTM settings for amplitude, paced percentage, and lead impedance.

The service life projections are based on the following assumptions: § Semi-annual maximum energy charging frequency § A quarterly schedule of remote telemetry transmissions § Typical shelf storage time before implant § 1 hour of wireless telemetry during implant § 1 hour of in-office wireless telemetry annually

Projected service life estimates are based on accelerated battery discharge data and device modeling as specified. Do not interpret these values as precise numbers.

Brief Statement CobaltTM/CromeTM MRI SureScanTM ICD and CRT-D Systems Indications: The Cobalt and Crome HF CRT-D MRI SureScan systems are indicated for use in patients who are at significant risk of developing atrial and/or life-threatening ventricular arrhythmias and who have heart failure with ventricular arrhythmias. Heart failure patients must have experienced one or more of the following conditions: § NYHA Functional Class III or IV patients who remain symptomatic despite stable, optimal medical
therapy and have LVEF  35% and a prolonged QRS duration § NYHA Functional Class II patients who have left bundle branch block (LBBB) with a QRS duration
 130 ms and a left ventricular ejection fraction  30% § NYHA Functional Class I, II, or III who are on stable, optimal medical therapy (if indicated) and have
LVEF  50%, atrioventricular block (AV block), and are expected to require a high percentage of ventricular pacing that cannot be managed with algorithms to minimize right ventricular pacing The Cobalt and Crome VR and DR ICD MRI SureScan systems are indicated for the automated treatment of patients who have experienced, or are at significant risk of developing, atrial and/or life-threatening ventricular arrhythmias through the delivery of antitachycardia pacing, cardioversion, and defibrillation therapies. MRI Conditions for Use: Medtronic SureScan ICD and CRT-D systems are MR Conditional, and as such are designed to allow patients to undergo MRI under the specified conditions for use. ICD and CRT-D SureScan system patients may be scanned using a horizontal field, cylindrical bore, clinical 1.5T or 3T MRI system for hydrogen proton imaging. When programmed to On, the MRI SureScan feature allows the patient to be safely scanned while the device continues to provide appropriate pacing. A complete SureScan defibrillation system, which is a SureScan device with appropriate SureScan lead(s), is required for use in the MR environment. To verify that components are part of a SureScan system, visit http://www.mrisurescan.com/. Any other combination may result in a hazard to the patient during an MRI scan.
Medtronic 710 Medtronic Parkway Minneapolis, MN 55432-5604 USA
Toll-free in USA: 800.633.8766 Worldwide: +1.763.514.4000

Contraindications: The Cobalt and Crome VR and DR ICD, and CRT-D MRI SureScan systems are contraindicated for use in the following situations: § If implanted with a unipolar pacemaker § If incessant VT or VF exists § If the primary disorder is chronic atrial tachyarrhythmia with no concomitant VT or VF § If tachyarrhythmias with transient or reversible causes exist, including the following known issues:
acute myocardial infarction, drug intoxication, drowning, electric shock, electrolyte imbalance, hypoxia, and sepsis Warnings and Precautions: Changes in a patient's disease and/or medications may alter the efficacy of the device's programmed parameters. Patients should avoid sources of magnetic and electromagnetic radiation to avoid possible underdetection, inappropriate sensing and/or therapy delivery, tissue damage, induction of an arrhythmia, device electrical reset, or device damage. Do not place transthoracic defibrillation paddles directly over the device. Patients and their implanted systems must be screened to meet the following requirements for MRI: no lead extenders, lead adaptors, or abandoned leads present; no broken leads or leads with intermittent electrical contact as confirmed by lead impedance history; the device must be operating within the projected service life; and the system must be implanted in the left or right pectoral region. Potential Adverse Events: Potential adverse events include, but are not limited to, the following events: allergic reactions, atrial fibrillation, bradyarrhythmia, cardiac arrest, device migration, discomfort, dizziness, dyspnea, erosion, excessive fibrotic tissue growth, heart failure or loss of CRT (for CRT-D patients), hematoma, hemorrhage, inability to deliver therapy, inappropriate shock, infection, lead migration/dislodgement, lethargy, loss of pacing, mental anguish, necrosis, nerve damage, oversensing, palpitations, seroma, syncope, tachyarrhythmia, tissue damage due to heating of the device, undersensing, and wound dehiscence. Potential MRI complications include, but are not limited to, lead electrode heating and tissue damage resulting in loss of sensing or capture or both, spontaneous tachyarrhythmia, potential for VT/VF induction, device heating that results in tissue damage, stimulation of the leads that results in continuous capture, VT/VF, hemodynamic collapse, damage to the device or the leads, causing the system to fail or treat the patient's condition incorrectly, and movement or vibration of the device or the leads, resulting in dislodgement. See the device manuals for detailed information regarding the implant procedure, indications, contraindications, warnings, precautions, and adverse events. See the MRI SureScan Technical Manual before performing an MRI Scan. For further information, call Medtronic at 1-800-328-2518 and/or consult the Medtronic website at medtronic.com or mrisurescan.com. Caution: Federal law (USA) restricts these devices to sale by or on the order of a physician.

medtronic.com
UC202001912 EN ©2020 Medtronic. Minneapolis, MN. All Rights Reserved. Printed in USA. 04/2020


Adobe InDesign 15.0 (Macintosh) Adobe PDF Library 15.0

Related Documents

Preview Medtronic Cobalt XT HF Quad CRT-D MRI SureScan System: Product Overview and Specifications
Detailed information on the Medtronic Cobalt XT HF Quad CRT-D MRI SureScan system (Model DTPA2QQ), covering its physical characteristics, device parameters, therapy settings, longevity, and MRI compatibility. Includes indications, contraindications, warnings, and precautions.
Preview Medtronic Cobalt HF CRT-D MRI SureScan DTPB2D4 Product Specifications
Detailed product specifications for the Medtronic Cobalt HF CRT-D MRI SureScan system, model DTPB2D4. This device offers advanced features for cardiac resynchronization therapy and defibrillation, including BlueSync Technology, AdaptivCRT, SmartShock 2.0, and MRI compatibility.
Preview Medtronic Cobalt ICDs and CRT-Ds: The Future of Cardiac Rhythm Management
Explore the Medtronic Cobalt ICDs and CRT-Ds, featuring an unmatched feature suite, reimagined connectivity with BlueSync™ technology, and streamlined workflows. Learn about extended longevity, SmartShock™ 2.0, AdaptivCRT™, and AF management.
Preview Medtronic Agent Authorization for FCC Applications
Authorization letter from Medtronic, Inc. granting Daniel L. Johnson the authority to act on behalf of the company for equipment authorization applications with the FCC.
Preview Medtronic Sphera™ DR MRI SureScan™ Pacing System and Leads: Specifications and Overview
Comprehensive overview of the Medtronic Sphera™ DR MRI SureScan™ pacing system, including physical characteristics, programmable parameters, and related leads like CapSureFix Novus MRI™ and SelectSecure™ MRI. Details on the C315 Delivery Catheter are also provided.
Preview Medtronic Cobalt XT ICDs and CRT-Ds: The Future of Cardiac Care
Explore the advanced features of Medtronic's Cobalt XT ICDs and CRT-Ds, designed for enhanced longevity, reimagined connectivity, and streamlined heart failure management. Discover innovative technologies like BlueSync, SmartShock 2.0, iATP, AdaptivCRT, and TriageHF.
Preview Medtronic Azure S SR MRI SureScan W3SR01 Pacemaker Specifications and Features
Detailed specifications, pacing parameters, MRI compatibility, and longevity data for the Medtronic Azure S SR MRI SureScan W3SR01 cardiac pacemaker.
Preview Medtronic Cobalt XT VR MRI SureScan ICD DVPA2D4 Technical Specifications
Detailed technical specifications for the Medtronic Cobalt XT VR MRI SureScan ICD Model DVPA2D4, including physical characteristics, replacement indicators, maximum energy levels, and comprehensive device and pacing parameters.